Marco de Bruyn Selected Research

Epithelial Cell Adhesion Molecule

4/2014

Targeted delivery of CD40L promotes restricted activation of antigen-presenting cells and induction of cancer cell death.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marco de Bruyn Research Topics

Disease

34	Neoplasms (Cancer) 01/2024 - 08/2008
3	Carcinoma (Carcinomatosis) 01/2023 - 04/2014
3	Ovarian Neoplasms (Ovarian Cancer) 12/2022 - 11/2016
3	Endometrial Neoplasms (Endometrial Cancer) 10/2020 - 07/2015
3	Melanoma (Melanoma, Malignant) 09/2013 - 11/2010
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 11/2016 - 01/2015
2	Rheumatoid Arthritis 09/2014 - 01/2011
2	Infections 06/2013 - 12/2008
1	Chromosomal Instability (Chromosome Stability) 01/2022
1	Rupture 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Triple Negative Breast Neoplasms 01/2022
1	Injection Site Reaction 01/2021
1	Bites and Stings (Sting) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019
1	Adenocarcinoma of Lung 01/2019
1	Tertiary Lymphoid Structures 01/2019
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2019
1	Ovarian Epithelial Carcinoma 10/2018
1	Carcinosarcoma 01/2018
1	Sarcoma (Soft Tissue Sarcoma) 01/2015
1	Multiple Sclerosis 09/2014
1	B-Cell Leukemia (Leukemia, B Cell) 04/2014
1	Asthma (Bronchial Asthma) 06/2013
1	Autoimmune Diseases (Autoimmune Disease) 01/2011
1	Reperfusion Injury 05/2010
1	Ischemia 05/2010

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2016
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2010
5	Immunoglobulin FragmentsIBA 04/2014 - 08/2008
4	AntigensIBA 01/2023 - 02/2016
4	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2019
4	LigandsIBA 09/2013 - 08/2008
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 10/2020
3	AntibodiesIBA 05/2021 - 01/2011
3	Messenger RNA (mRNA)IBA 01/2021 - 01/2019
2	IntegrinsIBA 11/2023 - 12/2022
2	Therapeutic UsesIBA 04/2022 - 01/2015
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2019
2	VaccinesIBA 01/2021 - 10/2018
2	Exonucleases (3' 5' Exonuclease)IBA 10/2020 - 07/2015
2	ErbB Receptors (EGF Receptor)IBA 01/2015 - 08/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015 - 08/2008
2	TNF-Related Apoptosis-Inducing LigandIBA 01/2015 - 12/2008
2	rimcazoleIBA 09/2013 - 11/2010
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2023
1	EpitopesIBA 12/2022
1	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2022
1	tocilizumab (atlizumab)FDA Link 01/2022
1	ametantrone (HAQ)IBA 01/2021
1	InterferonsIBA 01/2021
1	Cancer VaccinesIBA 01/2021
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2021
1	Epidermal Growth Factor (EGF)IBA 01/2019
1	Rituximab (Mabthera)FDA Link 01/2019
1	Chemokine CXCL13IBA 01/2019
1	B7-H1 AntigenIBA 01/2019
1	Programmed Cell Death 1 ReceptorIBA 01/2019
1	Oncogene Proteins (Oncogene Protein)IBA 01/2017
1	DNA Polymerase IIIBA 11/2016
1	CytokinesIBA 11/2016
1	Granzymes (Granzyme)IBA 07/2015
1	DNA replicaseIBA 07/2015
1	Galectins (Galectin)IBA 01/2015
1	Complement System Proteins (Complement)IBA 01/2015
1	Monoclonal AntibodiesIBA 01/2015
1	CalreticulinIBA 01/2015
1	Interleukin-17 (Interleukin 17)IBA 09/2014
1	InterleukinsIBA 09/2014
1	CD40 Ligand (CD40L)IBA 04/2014
1	Epithelial Cell Adhesion MoleculeIBA 04/2014
1	Glucose (Dextrose)FDA LinkGeneric 09/2013
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 09/2013
1	LectinsIBA 06/2013
1	Immunotoxins (Immunotoxin)IBA 05/2013
1	Surface Antigens (Surface Antigen)IBA 05/2013
1	Death Domain ReceptorsIBA 05/2013
1	Polysaccharides (Glycans)IBA 09/2012
1	Carrier Proteins (Binding Protein)IBA 09/2012
1	Chondroitin Sulfate ProteoglycansIBA 11/2010
1	tricarbonyldichlororuthenium (II) dimerIBA 05/2010
1	Recombinant Fusion ProteinsIBA 12/2008
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 08/2008

Therapy/Procedure

17	Therapeutics 01/2023 - 11/2010
12	Immunotherapy 01/2024 - 11/2010
3	Drug Therapy (Chemotherapy) 10/2020 - 01/2015
1	Precision Medicine 01/2024
1	Intravenous Injections 12/2022
1	Radiotherapy 10/2020
1	Adjuvant Chemotherapy 10/2020
1	Adjuvant Chemoradiotherapy 10/2020
1	Lymph Node Excision (Lymph Node Dissection) 01/2018
1	Surgical Instruments (Clip) 05/2010
1	Intraocular Injections 12/2008